Such systems would be particularly valuable for studying BAFF-driven pathologies like SLE -associated kidney damage or SS salivary gland dysfunction, enabling direct validation of therapeutic targets in a humanized context. This evidence concerns the gene TNFSF13B and synovial sarcoma.